These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 24456153

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Is the urinary biomarkers assessment a non-invasive approach to tubular lesions of the solitary kidney?
    Gadalean F, Kaycsa A, Gluhovschi G, Velciov S, Gluhovschi C, Bob F, Bozdog G, Petrica L.
    Ren Fail; 2013; 35(10):1358-64. PubMed ID: 23992109
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biomarkers in assessing tubular lesions of the solitary kidney. The solitary kidney in special conditions.
    Gluhovschi GH, Gadalean F, Gluhovschi C, Velciov S, Petrica L, Timar R, Anastasiu D, Gluhovschi A.
    Rom J Intern Med; 2013; 51(3-4):135-42. PubMed ID: 24620625
    [Abstract] [Full Text] [Related]

  • 5. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
    Gluhovschi C, Velciov S, Kaycsa A, Gluhovschi G, Petrica L, Marian R, Bozdog G, Gadalean F, Bob F, Cioca D, Vernic C.
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin.
    Gautier JC, Zhou X, Yang Y, Gury T, Qu Z, Palazzi X, Léonard JF, Slaoui M, Veeranagouda Y, Guizon I, Boitier E, Filali-Ansary A, van den Berg BHJ, Poetz O, Joos T, Zhang T, Wang J, Detilleux P, Li B.
    Toxicol Appl Pharmacol; 2016 Jul 15; 303():1-10. PubMed ID: 27105553
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. N-acetyl-beta-D-glucosaminidase enzymuria as an indicator in monitoring the therapy of some rheumatic diseases with potentially nephrotoxic drugs.
    Wiland P, Szechiński J.
    Arch Immunol Ther Exp (Warsz); 1994 Jul 15; 42(4):331-6. PubMed ID: 7487376
    [Abstract] [Full Text] [Related]

  • 9. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
    Gibey R, Dupond JL, Mallet H, Guerber F, Iehl-Robert M, Flausse-Parrot F, Becker M.
    Nephrologie; 1986 Jul 15; 7(2):51-5. PubMed ID: 3736764
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enzymuria determination in children treated with aminoglycosides drugs.
    Mohammadi-Karakani A, Asgharzadeh-Haghighi S, Ghazi-Khansari M, Seyed-Ebrahimi A, Ghasemi A, Jabari E.
    Hum Exp Toxicol; 2008 Dec 15; 27(12):879-82. PubMed ID: 19273542
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.